External Ventricular Drain Market (By Indication: Traumatic Brain Injury (TBI), Subarachnoid Hemorrhage into CSF, Meningitis, Posterior Fossa Tumor, Subdural Hematoma (SDH), Hematomas Posterior Fossa, IV Ventricle Obstruction, and Others; By End-User: Hospitals, Pediatric Care Center, Ambulatory Surgery Centers, and Others) - Global Market Size, Share, Growth, Trends Analysis, Regional Outlook and Forecasts 2022 - 2030

The global external ventricular drain market size was estimated at USD 2.64 billion in 2021 and is projected to hit USD 4.15 billion by 2030, expanding growth at a CAGR of 5.2% during the forecast period 2022 to 2030.

External Ventricular Drain Market Size 2020-2030

Major Trends in the External Ventricular Drain Industry:

An external ventricular drain (EVD) is employed for the drainage of CSF (cerebrospinal fluid) from the brain ventricles. The ventricular drainage arrangements are used to release elevated ICP (intracranial pressure), drain blood post hemorrhages, trench the infected cerebrospinal fluid, distract the stream of cerebrospinal liquid, and supervise the intracranial stress. A ventricular drainage apparatus contains an exterior drainage arrangement linked to ventricular catheter. The arrangement comprises numerous components like an ant reflux gathering chamber, access port, pressure scale, and drainage bag. It is typically inserted in the operation theatre by a brain surgeon, and the process is carried out with general anesthesia.

Over the recent past, the incidence of hydrocephalus has augmented significantly, enhancing the demand for EVD (external ventricular drain) as a procedure of treatment. The high incidence of hydrocephalus and the rising geriatric population are major aspects that are anticipated to drive the market progress over the forecast time-duration. The rising healthcare market in emerging economies is also anticipated to provide development opportunities for the external ventricular drain industry over the forecast duration.

The increasing prevalence of hydrocephalus is one of the major driving factors for the growth of global external ventricular drain market. Hydrocephalus is an atypical build-up of liquid in the ventricles (cavities) deep inside the brain. This surplus fluid induces the ventricles to broaden, putting stress on the tissues of the brain. Cerebrospinal fluid (CSF) is the colorless, clear fluid that shields and cushions the spine and brain. Usually, cerebrospinal fluid tides through the ventricles and rinses the spinal cord and brain before getting resorbed into the blood flow. The body stereotypically produces adequate CSF every day and engrosses the same quantity. Nevertheless, when the regular flow or assimilation of CSF is jammed it can lead to an aggregation of CSF. The stress from excessive CSF can restrain the brain from operating properly and induce brain damage and even demise. As per the Hydrocephalus Association, around 1 million individuals in the U.S. are affected by hydrocephalus, in each stage of lifetime, from newborns to the aged. Hydrocephalus can be extremely grave, and even lethal if left untreated. Around 50% of individuals who don’t undergo treatment for hydrocephalus die. While, the other half live with what is termed arrested hydrocephalus.

Crucial factors accountable for market growth are:

  • Growing incidence of neurological diseases
  • Growing focus on research and development in the field of neuro care
  • Rising number of traumatic brain injuries due to road accidents
  • Fast adoption of latest healthcare technology globally
  • Growing number of cranial injuries
  • Growing demand for less invasive neurosurgical procedures
  • Multiple advantages offered by external ventricular drain procedures
  • Rising awareness related to neurological disorders in low-income countries

COVID-19 Impact on Global External Ventricular Drain Market

The COVID-19 pandemic is attracting attention to the previously overburdened public healthcare systems in numerous countries. The pandemic has highlighted the strong necessity for sustainable outlay in healthcare arrangements, including in the healthcare workforce, and for prudent working conditions, equipment, and training specially with respect to PPE (personal protective equipment) and work-related safety. Augmented spending on investigation and advance along with collaborations, acquisition, and mergers are the central strategies adopted by the major companies active in the global external ventricular drain market.

Due to the overburden of the medical staff, the people who need periodic surgeries to drain out CSF (cerebrospinal fluid) and for the regular monitoring of CSF are at high risks in the wake of the current situation. Surgical amenities need a emergency plan for preserving surgical care in an on-going or post pandemic phase.

Scope of the External Ventricular Drain Market

Report Highlights Details
Market Size USD 4.15 Billion by 2030
Growth Rate CAGR of 5.2% From 2021 to 2030
Base Year 2021
Historic Data 2017 to 2021
Forecast Period 2022 to 2030
Segments Covered Indication, End-User
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)
Companies Mentioned Medtronic, Integra LifeSciences Corporation, Spiegelberg, Sophysa, Möller Medical, and Fugi Systems Corporation


Significant Market Trends:

Traumatic Brain Injury (TBI) Segment Reported Foremost Market Stake in 2020

The traumatic brain injury (TBI) displayed the major share in the worldwide external ventricular drain market in 2020. Increasing number of accidents leading to brain injuries is the key reason for highest market stake of software segment. The factors such as increasing number of sports injuries and technological advancements are expected to retain the dominance of software in the near future.

The meningitis segment is anticipated grow at the maximum CAGR through the forecast time-frame mainly due to high anticipated demand.

Hospitals Dominated the Market Revenue By End-User

High preference is given to hospitals for carrying out complex neurosurgical procedures. Moreover, hospitals are equipped with the latest equipment required for advanced procedures.

North America is Estimated to be the Largest Market for External Ventricular Drain

The detailed research report covers significant prospects and inclinations of external ventricular drain products throughout different regions including Europe, North America, Asia-Pacific, Africa, Middle East, and Latin America. By region, external ventricular drain market is led by North America due to early adoption of advanced healthcare technologies and availability of state-of-the-art healthcare infrastructure. Europe reported the second maximum share predominantly due to presence of key industry players and increasing geriatric population. Asia-Pacific is also anticipated to witness the rapid growth rate, on account of increasing investment by major manufacturers and high number of accidents.

Global External Ventricular Drain Market 2021-2030

Top Players contending in the Market:

The companies focusing on research and development are expected to lead the global external ventricular drain market. Leading competitors contending in global external ventricular drain market are as follows:

  • Medtronic
  • Integra LifeSciences Corporation
  • Spiegelberg
  • Sophysa
  • Möller Medical
  • Fugi Systems Corporation

In order to well recognize the present status of external ventricular drain, and policies implemented by the foremost nations, Precedence Research projected the future progress of the external ventricular drain market. This research report bids quantitative and qualitative insights on external ventricular drain market and valuation of market size and progress trend for probable market segments.

Recent Developments:

  • In June 2019, Integra LifeSciences took over Arkis Biosciences Inc. which offers a range of neurosurgical equipment’s, such as the CerebroFlo EVD catheter with Endexo technology, a perpetual additive intended to reduce the probability for catheter obstacle due to thrombus creation.

Major Market Segments Covered:

By Indication

  • Traumatic Brain Injury (TBI)
  • Subarachnoid Hemorrhage into CSF
  • Meningitis
  • Posterior Fossa Tumor
  • Subdural Hematoma (SDH)
  • Hematomas Posterior Fossa
  • IV Ventricle Obstruction
  • Others

By End-User

  • Hospitals
  • Pediatric Care Center
  • Ambulatory Surgery Centers
  • Others

By Geography

  • North America
      • U.S.
      • Canada
  • Europe
      • Germany
      • France
      • United Kingdom
      • Rest of Europe
  • Asia Pacific
      • China
      • Japan
      • India
      • Southeast Asia
      • Rest of Asia Pacific
  • Latin America
      • Brazil
      • Rest of Latin America
  • Middle East & Africa (MEA)
      • GCC
      • North Africa
      • South Africa
      • Rest of Middle East & Africa

Frequently Asked Questions

What is the current size of global external ventricular drain market?
Precedence Research says, the external ventricular drain market size was estimated at USD 2.64 billion in 2021 and is anticipated to surpass around USD 4.15 billion by 2030.
The global external ventricular drain market is growing at a CAGR of 5.2% during the estimate period 2022 to 2030.
The crucial factors accountable for external ventricular drain market growth are growing incidence of neurological diseases, rising number of traumatic brain injuries due to road accidents, fast adoption of latest healthcare technology globally and growing number of cranial injuries.
In 2020, the North America region dominated the worldwide market with a market share of higher than 42%.
The Asia Pacific region is projected to grow at the highest CAGR of around 6.8% in the estimate period due to increasing per capita healthcare expenditure and high number of accident-related brain injuries.Latin America and Middle East and African region will display noticeable growth.
Among the indication segment, traumatic brain injuries (TBI) dominated the overall market in 2020. The rising number of accidents, and sports-related injuries are the foremost factors attributing to its large market share.
The key companies functioning in the worldwide external ventricular drain market are Medtronic, Integra LifeSciences Corporation, Spiegelberg, Sophysa, Möller Medical, and Fugi Systems Corporation among others.
  • Report Code:1227
  • Category:Healthcare
  • No. of Pages:150+
  • Format:PDF/PPT/Excel
  • Status:Published


   USD 4500
   USD 7000
   USD 9000


No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client

Get a Sample